Literature DB >> 28637408

Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non- Alcoholic Steatohepatitis.

Konstantinos Stavropoulos1, Konstantinos Imprialos1, Andreas Pittaras2, Charles Faselis2, Puneet Narayan2, Peter Kokkinos2.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is one of the most common diseases worldwide, affecting more than 30% of general population. High-fat diets, physical inactivity and obesity, all prevalent in the western societies, are strongly associated with the development and progression of NAFLD. Current drug therapies have not consistently shown substantial beneficial effects. Thus, lifestyle modification appears to be the optimal intervention in combating the disease. Accordingly, several studies have concluded that weight loss, via increase in physical activity, and dietary interventions could potential ameliorate biochemical, histological, and structural abnormalities of non-alcoholic fatty liver disease. The aim of this review is to summarize the findings of these lifestyle intervention studies and discuss the implementation of each intervention, and its effectiveness in the management of the disease in everyday clinical practice. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Non-alcoholic fatty liver disease; diet.; lifestyle modification; non-alcoholic steatohepatitis; nutrition; physical activity; weight loss

Mesh:

Year:  2018        PMID: 28637408     DOI: 10.2174/1570161115666170621080835

Source DB:  PubMed          Journal:  Curr Vasc Pharmacol        ISSN: 1570-1611            Impact factor:   2.719


  6 in total

1.  Sheng-Jiang Powder Ameliorates High Fat Diet Induced Nonalcoholic Fatty Liver Disease via Inhibiting Activation of Akt/mTOR/S6 Pathway in Rats.

Authors:  Juan Li; Lv Zhu; Yu-Mei Zhang; Huan Chen; Yi-Fan Miao; Hong-Xin Kang; Hong-Yu Ren; Mei-Hua Wan; Dan Long; Wen-Fu Tang
Journal:  Evid Based Complement Alternat Med       Date:  2018-10-04       Impact factor: 2.629

2.  Dietary DHA/EPA Ratio Changes Fatty Acid Composition and Attenuates Diet-Induced Accumulation of Lipid in the Liver of ApoE-/- Mice.

Authors:  Liang Liu; Qinling Hu; Huihui Wu; Xiujing Wang; Chao Gao; Guoxun Chen; Ping Yao; Zhiyong Gong
Journal:  Oxid Med Cell Longev       Date:  2018-11-14       Impact factor: 6.543

3.  Atorvastatin promotes AMPK signaling to protect against high fat diet-induced non-alcoholic fatty liver in golden hamsters.

Authors:  Bin Zhang; Chenyang Zhang; Xuelian Zhang; Nannan Li; Zhengqi Dong; Guibo Sun; Xiaobo Sun
Journal:  Exp Ther Med       Date:  2020-01-22       Impact factor: 2.447

Review 4.  Mediterranean Diet and NAFLD: What We Know and Questions That Still Need to Be Answered.

Authors:  Maria Corina Plaz Torres; Alessio Aghemo; Ana Lleo; Giorgia Bodini; Manuele Furnari; Elisa Marabotto; Luca Miele; Edoardo G Giannini
Journal:  Nutrients       Date:  2019-12-05       Impact factor: 5.717

5.  Exercise Affects the Formation and Recovery of Alcoholic Liver Disease through the IL-6-p47phox Oxidative-Stress Axis.

Authors:  Wei Cui; Xiang Li; Weiyue Xue; Huiting Wei; Gang Zhou; Ye Qiu; Di Cui
Journal:  Cells       Date:  2022-04-12       Impact factor: 7.666

Review 6.  Individualized treatment options for patients with non-cirrhotic and cirrhotic liver disease.

Authors:  Lukas Hartl; Joshua Elias; Gerhard Prager; Thomas Reiberger; Lukas W Unger
Journal:  World J Gastroenterol       Date:  2021-05-21       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.